BioCentury
ARTICLE | Clinical News

ABX-1431: Phase Ia started

July 27, 2015 7:00 AM UTC

Abide began a double-blind, placebo-controlled, Belgian Phase Ia trial to evaluate single and multiple ascending doses of ABX-1431 in about 60 healthy volunteers. Abide said potential indications incl...